Chemical Compounds
Eplerenone
100%
Mineralocorticoid
83%
Aldosterone
74%
Angiotensin II
44%
Mineralocorticoid Antagonist
31%
dUTP
27%
Intraperitoneal
22%
Agent Interacting With Transmitter, Hormone or Drug Receptor
19%
Glutathione
15%
Peroxidase
15%
Plasma
10%
Weight
9%
Protein
7%
Time
6%
Agriculture & Biology
mineralocorticoid receptors
84%
cardiomyopathy
74%
diabetes mellitus
68%
receptors
35%
mice
30%
aldosterone
20%
angiotensin II
10%
antagonists
7%
coronary artery disease
6%
streptozotocin
5%
angiotensins
5%
renin
5%
NAD(P)H oxidase (H2O2-forming)
5%
intraperitoneal injection
4%
hypertension
4%
immunohistochemistry
4%
transferases
4%
glutathione peroxidase
4%
pathogenesis
4%
tissues
3%
protein synthesis
3%
staining
3%
breeds
3%
body weight
2%
cells
1%
methodology
1%
Medicine & Life Sciences
Diabetic Cardiomyopathies
73%
Mineralocorticoid Receptors
68%
Diabetes Mellitus
41%
Eplerenone
20%
Aldosterone
13%
Angiotensin Type 1 Receptor
10%
Knockout Mice
8%
phospholamban
6%
Mineralocorticoid Receptor Antagonists
5%
4-hydroxy-2-nonenal
5%
DNA Nucleotidylexotransferase
5%
NADPH Oxidases
5%
Messenger RNA
5%
Left Ventricular Dysfunction
4%
Glutathione Peroxidase
4%
Renin-Angiotensin System
4%
Streptozocin
4%
Intraperitoneal Injections
4%
Left Ventricular Function
4%
Coronary Artery Disease
3%
Body Weight
3%
Down-Regulation
3%
Immunohistochemistry
3%
Hypertension
2%
Staining and Labeling
2%
Proteins
1%